Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
about
Cancer treatment using an optically inert Rose Bengal derivative combined with pulsed focused ultrasound.Pulsed high-intensity-focused US and tissue plasminogen activator (TPA) versus TPA alone for thrombolysis of occluded bypass graft in swine.Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal modelsUltrasound-enhanced drug delivery for cancerMR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment.A simulation technique for 3D MR-guided acoustic radiation force imaging.Quantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study.Modulation of the interstitial fluid pressure by high intensity focused ultrasound as a way to alter local fluid and solute movement: insights from a mathematical model.Distribution of doxorubicin in rats undergoing ultrasonic drug deliveryHigh-intensity focused ultrasound surgery of the brain: part 1--A historical perspective with modern applicationsPulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors.MRI-based prediction of pulsed high-intensity focused ultrasound effect on tissue transport in rabbit muscleShort-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications.Pulsed focused ultrasound exposures enhance locally administered gene therapy in a murine solid tumor model.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.MRI-Guided Focused Ultrasound as a New Method of Drug Delivery.Estimation of thermal dose from MR thermometry during application of nonablative pulsed high intensity focused ultrasound.Phase-shift, stimuli-responsive drug carriers for targeted delivery.Ultrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrug.Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.An optimum method for pulsed high intensity focused ultrasound treatment of large volumes using the InSightec ExAblate® 2000 systemDesign and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism.Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle.In vitro and in vivo evaluations of increased effective beam width for heat deposition using a split focus high intensity ultrasound (HIFU) transducer.Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib.Ultrasound mediated delivery of drugs and genes to solid tumors.Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directionsPulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study.Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy.Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.Nanotechnology for energy-based cancer therapiesCancer therapy using nanoformulated substances: scientific, regulatory and financial aspects.Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
P2860
Q28246514-0305A6BB-AE61-4367-B62D-1775E0ABDDC1Q28267010-48360909-AE70-4531-94AF-E2529DD95A73Q28538039-03739412-0DD3-43E6-BBE3-C771F5195572Q29035807-EE18747C-CC35-48FA-946B-8026C14FD2D2Q30372703-33F0E7FD-DB79-4804-BE9D-A73BF7A44B97Q30392458-9FC373BE-4322-42BC-A46D-E5DAA289999CQ30397585-58A417FE-68A6-4112-AA55-DBCFDBF98C4DQ30398463-26E60272-C7E3-4B6E-8D40-E5B11A8AC8F2Q30404975-ED309D15-D479-430C-B607-28D1BBFED8DFQ30412356-447AD0B1-679A-4ADD-ADC4-41872F1920C1Q30426788-F52FA8BC-9B4F-4ADF-97B8-5456064A68B0Q30427143-F0A6FEE4-48CD-4E93-AD76-994DBB82D9DEQ30429246-2EB3805F-D5F8-4B61-9E72-71FB62549E52Q30429594-2ABF3503-75D3-41D1-86A1-13F0D6703D87Q30442329-B87FE2E4-45C1-4522-BB9B-E5159489AD67Q30450131-3DEA5792-A75C-43A0-8C4E-2620C6EC0D4BQ30453855-128C1716-66C0-4FC8-AB9B-15D87AAA7EBBQ30455026-DB8FD874-0DD3-48B8-AD7D-EA2C1AB3C8DEQ30466278-DFB4859D-BDEC-4DD3-BA17-A5E5BCC79448Q30467420-D43F021F-775B-4ACE-831C-A9C4742338D0Q30469830-F397E47A-48B2-41AF-AA73-D7DEA4EF48EBQ30473166-81BB9812-D558-40D9-B77A-59E18B1463E1Q30477892-B3FAFC9A-6A7A-489B-A03A-9A4496CA51E6Q30479437-EC1AECEF-94FE-4FA9-AC72-6867CA443C4DQ30483072-20FCDAF5-E76D-414C-BE4E-A8FCCCC0A23CQ30485622-8C419F00-B268-4C95-AC3A-7D42BDCAC65FQ30487871-411A715A-1311-44C2-998C-9243E57B66DDQ30488681-CDE5146C-D810-4BC9-8168-8B398A5755D9Q30493238-A0545F88-CDC3-4C81-9D2C-6383D815A26EQ30494120-CB83B6AF-D983-4B6C-BADC-38E4EFA7809EQ30499214-22A87BA0-2262-4022-8499-292D36CE622EQ30514138-76078542-A99E-4371-A205-706BE7F86FA7Q31123144-5D8FD8BF-9C63-4712-8B74-24511CDFDD18Q34258440-DA0B6C01-10BA-48C0-8D58-F6D73F6F8429Q34777812-60566F68-134B-447A-972D-7C0A1D0ADFEFQ35188633-8DAA1E76-4D45-4826-84BE-2595C983A352Q35264028-7397F5A2-D8E9-4905-AB75-428963814DABQ35786517-7D15B458-A9F0-42D7-BE34-63CA368C9BD8Q36723768-E95FBE37-12A6-4EBA-8D8B-4E2E565E3972Q37066550-4F672C4E-039C-4872-A63F-E4959E623702
P2860
Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@ast
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@en
type
label
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@ast
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@en
prefLabel
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@ast
Delivery of liposomal doxorubi ...... y focused ultrasound exposure.
@en
P2093
P1433
P1476
Delivery of liposomal doxorubi ...... ty focused ultrasound exposure
@en
P2093
Amena Etherington
Finie Hunter
Jade Quijano
Jianwu Xie
Maiya Greene
Sergio Dromi
Victor Frenkel
P304
P356
10.1016/J.ACRA.2005.08.024
P50
P577
2006-04-01T00:00:00Z